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N EI’I‘HER the frequency nor the importance of the debilitating and fatal consequences 
of thromlx~embolic disease has heen fully appre- 
ciated t)y must physicians. The following data 
are presented to stress the high frequent)- of this 
disease. the serious and important nature of its 
associated sequelae and the difficulties en- 
countered in making the clinical diagnosis. 
Deep \.enous thrombosis and pulmonar>- eln- 
holism are disorders of major significance and 
are responsible for much long term disahilit!. 
and an appreciable mortalit>-. If there is to l)c 
a real reduction in the incidence of pulmonar! 
eml)olism and the postphlebitic syndrome of 
edema, induration and ulceration, there must 
I;c a greater awareness on the part of the clini- 
cian of the many and \-aried manifestations of 
throm t)oembolism. of the value of prompt and 
cffecti\-c treatment and of procedure< for prc- 
vention. 
Estrapulation of data obtained at our hospital 
to mortalit) statistics of the United States 
suggwt‘: that tlicre ma!. he as man) as 47,000 
death5 annuall!- in the Cnited States in \vhich 
pulmonar)- cmholism is the sole cause; in 
addition, there ma). lx three times this man) 
deaths in which pulmonary cmholim has at 
least plaxwl a significant role in the outcome. 
There’are no good mass surveys on the inci- 
dence of ulcers of the leg among the population 
of the LTnited States. Ro)-d et al.’ suggest that 
in England it is allout fi\-e per thousand popula- 
tion. If this figure can be applied to our popu- 
lation. there may be as man). as 850.000 people 
in the United States with ulceration of the leg, 
the majority secondary to postphlebitic change. 
The incidence of the other manifestations of the 
postphlet,itic syndrome must Iw considerably 
higher than this. 
A number of studies have shown that prompt 
diagnosis and adequate treatment of deep 
venous thrombosis can apprecia hly lower the 
incidence of emtlolic mortality and the signifi- 
cant disability associated xrlth postphlebitic 
requelae. Particularl>- with regard to pul- 
monary eml)olism, there ih a real need to 
achiew a much higher diagnostic rate if one 
hopes to lower significantly the mortality rate 
from this coinplication. A rc\-iew of the records 
of laryc autopsy series at our hospital’ has sho\vn 
that in only 10.6 per cent of patients with 
prwed pulmonary emboli was a clinical diag- 
nosis of \-enous thromt)osis made prior to death. 
III another X.6 per cent of these patients localiz- 
in!: signs, I\-hlch should have resulted in a 
diag-nosis of deep venous thromlwsis of the leq, 
IV& present. The difficulties in diagnosis of 
this entity are illustrated I)), the fact that in the 
remainin? patients (80.8 per crnt 1 thcrc were 
no signs or svmptoms suggesting any tllroml)oric 
prow+ in tlie \,eins of the leg. despite the fact 
that a maximum of less than 10 per cent of all 
ernholi could have arisen from a cardiac source. 
Tile repeated demonstration of a high failure 
rate in tllr clinical diagnosis of ti~rorrlI,ueml)olic 
disease precludes the prescntntion of accurate 
figures on the incidence of this dixease in a 
hospital population. Estimates Ixwd on the 
constant Iwt rather low clinical diagnosis 
rate as proved at autopsy, plus prior figures 
obtained in clinically diagnosed cases of throm- 
1xxmtxJism at our hospital, suggest that as man! 
as 6 per cent of hospitalized patients have deep 
vu~ous throml)osis, largely undiaqnosrd? during 
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their hospital stay. (This is admittedl)- only a 
,gross estimate; it is based on reasonal,ly accu- 
rate data obtained from autopsv records, the per- 
centage of cases diagnosed clinically, ratios he- 
tween the incidence of deep \.enous throlnt)osis 
and fatal ernboiism, etc. However, this fiqure 
has been derived t,)- several different technics, 
and the approximate incidence of 6 per cent 
has been ohtaincd in each instance.) 
Uuei, I ~mous Thrombosis: \Ve strongl), believe 
that there is no justification for the clinical 
differentiation of the aseptic form of deep 
venous thrombosis into “phlel>othroml,osis” and 
“thromt)ophlel~itis.” These terms, in our opin- 
ion, represent different phases of the same 
disease. Organization of a throml)us in an) 
vessel is associated lvith a sterile inflarnmator)- 
reaction and round cell infiltration. The 
manifestations attributed to “throl~lt)ophlel)itis” 
merely represent an ad\.ancecl stage of a throm- 
I)otic process which is sufliciently extcnsi\,e and 
severe so that deep-lying pathologic chan,qes are 
reflected in superficial signs. Our studies have 
shown that it is fallacious to maintain that 
patients with “throml~ophlet~itis” are secure 
from pulmonary eml~olism : pulmonar)- emboli 
develop in a number of patients with the classic 
signs of thrombophlebitis. .Although certain 
portions of a thrombus ma): be firmly attached 
to the vein wall, the propagating proximal tail 
of the thrombus is usually “free floating” and 
may- easily fragment and result in pulmonary 
emholism. In addition, there is no histologic 
tjasis for distinguishing these entities. We have 
sectioned a number of thrombosed veins; One 
area will demonstrate round cell infiltration of 
the vein wall (supposedl)- characteristic of 
thrombophlebitis) while another section through 
the same thromhus a few millimeters away will 
show no sign of sterile inflammatory change in 
the vein wall. 
C’njortunately, the majority sf c;t>isodes oj’ deeI) 
~nous thrombosis arp not associated witfz an?’ signs 
or symptoms. ,411 too frequently tfiejirst indication of 
venous tfrrombosis of the leg is the sudden death of the 
patient from fatal pulmonary embolism. In our 
series, even though the presence of iliac or 
caval thrombi was proved at autopsy, only half 
the patients had associated clinical signs, and 
many of these demonstrated only minimal 
unilateral edema. Complete but localized oc- 
clusion of the iliac vein will not produce edema 
if tlicre is an adcquatc nuinl~el- ol collarerai 
channels for th(s return of LW~OUS I~lood. It is 
unl>r Lvhen there is cjcclusion of man)- colla tcral 
channels as \vcxll that edema is present. 
The signs ai~cl symptoms of deep \cnous 
ttiromi~osis may I)t‘ \.asue or totally non-rxistcnt. 
Karel!-, plantar or calf pain \vill I)c prrWtit. 
It is usually dull and achinS in character, IJut 
occasionall!-, patients will complain of true 
cramps in the calf of the Its. biThen pain is 
prcsrnt, there is I’requcntl\. an associated tcndcr- 
IKSS along some portion of the course of the deep 
vcimus systmii, iti tllc plantar region of the foot, 
I)ct\vcen the hcllics of the gastrocncmius, in the 
popliteal area, alon? the femoral canal or in the 
lower part of tilr al~cloincn over the course of 
the iliac veins. I.ocal heat and redness inab- Ix 
noted in rare instances. Fever and tact,)-&rdia 
niav lx sug,gcsti\,e findings, but frequently theqe 
manifestations may lit explained a\vay as clue to 
otlirr causes. In the usual cast! even if prcYnt. 
thr5c signs are of little diagnostic valur. 
Much more frcqueritly, the onl!. clinical sign 
suqg’rstinq the prcscncc of a thromI,us occluding 
the clccp vcnoux qy.rtem is edema. UniLltera I 
rdcuia of the leg or asynmetrical hilatcral edema 
should IX conyidered as diagnostic of deep 
\~cnous throml)osis unless another cause can I)e 
definitely provccl. L-nfortunarel~, IY3Xusc of 
the frequent association of congestive 1Icar.t 
failure and throml~oeml~olisn~, apparentl!. equal 
edema of both lcq-s \vill often IX present to confusr 
the clinical picrurc. In this situation, however, 
edema is often more marked in the leg invc>l\,ecl. 
7‘lif~ .‘;rltic I:cir-tn /$ I)w/I 1 TOM Tf~rornhori.~~ 
(“,%/~tic ‘I%-,-ombo~~fil~~hrfis”): Since the advent of 
antibiotic therapy, this form of throml~oe~nl~ulic 
disease is rare. Fever is frequentl>- higher rhan 
that seen lvith axeptic venous throml)osis, l)ut 
they-e are no specific diagnostic signs. Such 21 
process usually occurs in association with prl\ic 
inflammatory disease which mav result front 
operations 011 pelvic structures. childbirth, 
abortions, appendiccal aljscess, etc. Pelvic 
examination ma! rr~-ral some tenderness, local 
heat, fluctuation or induration in the Inroad 
ligarnents or along the pelvic floor. Fe\-er is 
usually- of longer duration than in the aseptic 
form of this disease. Not infrequently, the 
diagnosis becomes apparent only after septic 
emt)oli have produced septic infarcts and 
secondary abscesses of the lung. Diagnosis is 
dependent on thr demont2tration of some septic 
process in close relationship with a portion of the 
deep \‘enous systeln. 
THE .AMERlCAN JOURNAI. OF CARDIOLOGY 
Ijeep Venous ‘Ih-ombosis and Pulmonary Embolism 013 
.. 7‘rouwuu S)dron~e“ (“Migrutor~ 7‘iirombo- 
phlrhitis” 1: ‘I‘hrombosis involving Attier supcr- 
ficiat or deep venous segments in more tlian one 
area, either concurrently or separated I)! con- 
sideraljle periods of time, deserve5 special attell- 
Lion. A history of spontancousl~- clc\~c~lopiiy 
throml~osis in superficial veins of the. arm. 
al)domen or Icy:, frcyucntl\- linked with \-enouh 
throml~osis of the deep \.eins of tlw leg. lvar‘ranth 
careful diagnostic work-up. The following 
diheasc entities moht frequrntl~- associated with 
this picture are thwc \vhich Trouwau ori+nall\ 
linked with migratory thrombophlebitis: (1’1 
tllrornt)o;trlgiitis oljliterans; (2) polyc) themia 
ruljra Vera : (3) hidden carcinoma, especially of 
the sto~nactl, palw’eas or lung : and (4 1 
cc&~y:cn disease. 
l)(i?/) 1 .txo7~s Ttcromhosis rcitlr Si,gn$c.ant _ 11 tuifi- 
.\/uI.\m (I’hlrgmasic~ Chulea Dolrns): Almost all 
case5 of massive v~wous occlusion of the ley arc’ 
associated \vith some degree of artcriospasm. 
One of the synonyms for iliofemoral \~enou5 
throml~osis is “phlegmasia alba dolens.” indicat- 
ill< the pallor of 111~ leg thought to IX due to 
spasm of the arteries accompanying the sterile 
inflammation of the vein. N%en venous throm- 
I)osis of the leg and arteriospasm are of such a 
degree that c)-anosis (cerulea = I~luc‘i is present. 
a serious situation exists, and the GalAit\ of the 
lty ina)’ I)e in question. It is essential tilat tlii.\ 
entity he recognized promptly and differentiated 
from primary arterial thrombosis or arterial 
embolism, since the approach to treatment ii 
somew hat differen t. ,4 pale cold leq with ol)- 
\?ous signs of arterial insufficiency ma)- present 
a difficult diagnostic problem : fortunatel>-, in 
tlic usual case of phlegmasia cerulea ctolens. 
marked edema of the leg is prrscnt. Such a 
lindiny associated with signs of acute arterial 
insufficicwzy should suggest the presence of a 
thromhus involving the \wious system. One 
xhould not expect to see edema of the leq in the 
varlv phase of primar,- arterial obstruction: scc- 
ondary \~cnous occlusion may occur after a period 
of complete arterial occlusion, but it is not an 
<‘arly finding. Rarely-, massive venous occlusion 
and the associated arteriospasm may occur so 
rapidly that there is no time for edema to 
de\.clop. In these instances, WC believe that 
rapid institution of specific treatment for phleg- 
masia cerulea dolens (continuous cpidural 
synpathetic Mock and intravenous administra- 
tion of heparin) is imperative. These measure\ 
will not interfere with subsequent therapy if 
it is later decided that the primar\, abnormalit> 
is arterial thronil~osis or emt~olism. ;\rtcrio- 
spasm \vitt usu;~lly he promptly relieved 1)) this 
ryimen. If arteriospasm remains unrecognized 
for a considcrat~le period of time, wcontlar~ 
arterial tliroml,osis ma) super\-enc. and tl1e 
vciwus throiiil~osis becomes more cstensi\.c.. In 
tlicw casch, the prognosis for srirvi\ al of tllc leg 
is poor: arterial ~hronil)ectoni) is uf little \ aluc 
5ince mas\i\.e 1 cnous ucclusion usually prt‘\ cnts 
tile rc-estat)lishment of adequate arterial uutflwv. 
Pulrnonar~ f?:‘lrrhvlism: All too frcquenrl! rhe 
first clinical sign of a throml)us in the leg or 
pelvic veins is one of the carcliorc~l~irator~- 
manifestations of pulmonar)- embolism. 1 few, 
ax with deep venous throml~osis, clinical recog- 
nition is the c,xccption rather tlliltl tt;c. rule. 
Even wrhcii ail einbolus has occluded ;I Iliii,jt)r 
I)ranch of the pulnionar)~ arterial tree. tllcrc 
ma\- be no definite sign to aid in the cliasllohis. 
In our \tudics of 606 patients wit11 pullllonar\- 
cmMi proved at autopsy, a ’ dehniri\,c diaynusis 
was ~naclc prior to death in onI\ 7 per eelit of the 
cases. Diagnostic failure \vas ~~suatl~ due cithe1 
to the minimal period of time I)etwcn onwt of 
s\ mptoms and death or to the oI)scurc Ilature 
of the clinical manifestations of the pulnionar\ 
eiril,olus. Of those patients in I\-ho111 pul- 
moniirv einl~olisin was thought to 1~ a in;3]0~ 
factor in producing death, one-fifth dicct ah&t 
ilnmedia tely, ,Ind almost half of the patients 
were dead within fifteen nlinutes. Thih lea\ es 
little time for careful e\.aluation and the initia- 
tion of treatment. 
AssessinS 501 embolic episodes in 383 parients 
\vith sig-nifiicant pulmonar) cnil~olisin (i.e.. 
emholism which was a ina,jor contriltutory 
factor or the sole cause of death), it \vas found 
that pulnionary enit)olisni withut infarction 
\viis responsible fur few if an)- characteristic 
signs or wnptoms. Pulmonary embolism 1% itll- 
out associated infarction mav result in sudden 
death or there may he &rtness uf I)rratll, 
h) potciision ur cyanosis. Chest pain ib es- 
tremel~- rare? and, ‘if present, is usually ;I transi- 
tory dull precordial discomfort. 
If pulmonary, infarction is present, typical or 
atypical plrurltic chest pain is more frequent, 
although it is still found in less tllan half of the 
patients. Hemoptysis occurs only wlwn infarc- 
tion is present and then only in one pa ticnt in 
five. 
,4 peripheral infarct will occasionally produce 
a friction rub, Ijut this finding is rare. However, 
friction rubs are frequently- missed because the) 
are transitorv. To detect this al)normalit)- the 
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chest of a patient with suspected pulmonary 
embolism must be examined at repeated in- 
tcrvals. 
Thr so-called classic triad of chest pain, 
shortness of breath and hemoptysis was found 
in onl). 3 per cent of major embolic episodes 
occuring in our patients. 
A sense of ate’areness of the z#ariable and Jrequently 
oh.s~uw manifestations of pulmonary embolism should 
alert the rlinlrian to the possihilitv that this conditin 
may exist in a patient unexf,lainrd 
IN TIIE PREDICTION AND DIAGNOSIS OF 
THROMBOEMBOI.IC DISEASE 
Ei'lDEhIIOL.OGIC COKSIDERATIONS 
Certain factors in the history and general 
medical evaluation may help in making the 
decision as to treatment of an equi\rocal case 
and in the selection of patients for prophylactic 
therap)-. Pre\ious studies” ha\-e indicated that 
the incidence of throml~oemt~olic disease is 
much higher \vhen certain epidemiologic factors 
arc present. 
Prior History of Tl~romboembolir Disease: A prior 
historv of deep venous thrombosis or pulmonar! 
eml&m. 110 matter how remote, is of such 
ominous prognostic import that \ve recommend 
proph!,lactic anticoagulant therap)- in any- 
patient with such a histor)- \\-ho requires an) 
significant restriction of actnit)-. Patients in 
this group with suspicious signs referable to the 
leg5 or chest should receive immediate treat- 
111r11t. 
Heart Ilisease: Ct’hen all patients with heart 
discasc (including those not in heart failure) 
arc considered, pulmonary embolism is three 
and a half times more frequent in this group of 
patients than in those without heart disease or 
cancer. The presence of auricular fibrillation 
or congestive heart failure increases the incidence 
al)out tenfold. 
Canrer: Malignant neoplasms of the gastro- 
intestinal tract, lung, or genitourinary tract 
increase the risk of thromt~oemlx~lism about 
fourfold. Other neoplasms have a much lesser 
effect. 
7’rauma to the I,eg: Bauer” has reported an 
eightfold increase in thromboem tjolic complica- 
tions following trauma to the leg. 
Obesity: Extreme obesity is associated with a 
twofold increase in the risk of thromt~oemt~olisrn. 
Immobility; Gibbs5 has shown a direct relation- 
ship between the degree and length of immo- 
bility and the incidence of tlrromlxen~l~olic 
disease. Regardless of the reason for the 
immobility (operation, fracture, parallxis, ser- 
ious medical illness)? this appears to I)e a critical 
factor. 
The presence of one or more of these epidemio- 
logic factors should make one more willing 
to treat an equivocal case in which clinical 
evidence alone is inadequate to make a definitiI,e 
diagnosis. 
CLINICAL TESTS 
lenous Thrombosis: It is our impression that 
Homans’ sign (pain in the calf on dorsiflcxion 
of the foot) is of little or no value in diagnosis 
hecause of the high percentage of false positive 
and false negative results. Tenderness OII direct 
palpation o\er the course of the deep \cnous 
s)-stem is much more specific: in the aljsencc of 
demonstrable tenderness hy this approach, \ve 
discount the significance of Homans’ sign. 
Measurements of the leg taken at different 
le\cls, carefull>- determined from a fixed point 
(the superior margin of the medial malleoIus), 
are of real value. 
A more olj,jcctive evaluation of pain of the 
calf or thigh ma)- I)e obtained 1)~ slowly inflating 
a sph)-gmomanomrter cuff placed about the 
part. Lo\venlxrg” reports that the pressurr at 
which the patient notes pain is consideral)l>. 
lobrer when \‘enous tlircjmtxGs is prcscnt. OUI 
experience \vitli this test is limited, t)ut it de- 
serves more extensive use to determine its 
value in detccring subclinical cases of clccp 
\cnous throml)osis. 
Occasionall>-, in a patient with pain of an 
equivocal nature in one leg, \ve have iii,jectecl 
intra\renousl>. a therapeutic dose of heparin 
(75 to 100 111,g.j: relief of pain following this 
procedure is taken as additional suggestive cvi- 
dence of deep \.enous thrombosis. 
In the past, our laboratory has evaluated a 
number of tests of various components of the 
clotting mechanism. None has proved of value, 
at our present state of knowledge, in detecting 
the tendency to, or the presence of, thromt)o- 
embolic disease. 
Pulmonary Embolism: Roentgenograms arc of 
little use in the diagnosis of pulmonary emho- 
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lisnt. The roentgenographic picture of pul- 
monary infarction is variable and non-specific. 
The so-called classic example of a wedge-shaped 
infarction is extremely rare. The usual pul- 
monary- infarct is a non-specific pultnonar\. 
densit)- Lvhich is frequently mistaken for atelecta- 
sis or pncutnoni;t Qui;e frequently a small 
pleural effusion is present. It is our belief that 
0 smull pit~ir7ol e8rr.r/of/ clt thr husr 01 llie hg zoitii or 
rc~itilorrf (I cli~monstrc~l~lr pdmnnar~ ~riuxzt7: should hr 
I rinciduc ti (is riqg;S’sti7,r rorlltgmogrot,ki~ widvncu of 
/dmonfli~y in[ilrctinv irnkss nnoth drjnite MIISP C(IV 
hr pror,tvi. 
.l’he rlrc Ir,,c,nrrliogr/lrn is a frequently neglected 
aid in tlie diagnosis of pulmonary embolisni. 
Elcctroc~trcliogral)hic abnormalities can I)e found 
in a high pcrcentngc of patients with pulmonar\- 
cntlwli. Tracings should be olltained earl>- itl 
the course of the disease in order to obtain infor- 
ma tion of L-alue. Serial records at frequent 
inter\-als may Ix helpful when characteristic 
c~lcctrocarclio:rray,llic changes are no1 seen 
initiall\ and when the diagnosis remains in 
cloul~~. Tltc so-called acute c& pulmonalc rye 
of clerrrocardiogratn is infrequently sew. Tlte 
mow cotnttion changes are a shift of the rlcc- 
trical axis to the right, incomplete or complete 
right I~tndle branch block, 7‘ czave in\wsic)n 
in riyhc percordial leads: KST segment deprcs- 
Gon in left precordial leads, tall pointed P \vavcs 
in the litnlt leads (“P pulmonale”) or the onset 
of an ;Itrial art++-thmia. 
\Ihilc these specific findings often support tlte 
clinical diag-nosi; of pulmonary eml)olistn and, 
in certain combinations, ma)- even be stronqly 
suyx:cyti\,c of this condition, the evolution and 
re5y2+.ion of the electrocardiographic aljnor- 
malitics arc eqttally important. \Vhen these 
cltangc~s result ft orn pulmonary embolism, tlic) 
usually- revert totvard nortnal in a tnatter of 
w.cral clays or \vceks. Tracings taken before 
the suspected embolism, if available, are \,alua- 
I)lc for purposes of comparison. 
<:oat~~~.tc:.~.~to~s .\ND SEQUELAE OF DEEP \-EP;OUS 
THRohrBoSIs 
Siwrr Srferiospusm (Phlegmasia Chlea Dolen i) : 
The problems in diagnosis and the hazards of 
this complication have already been mentioned. 
Pulmonary Emholism: It has been estimated 
that, without adequate treatment, one patient 
in three with deep venous thrombosis will have a 
pulmonary emt)olus. Of those patients with 
pultnonary embolism who remain untreated, by 
the most conservative estimates, at least one 
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patient in five will die from a ~econcl fatal pul- 
monary emttolus. Th is means that failure to 
apply specific therapeutic measures to it patient 
with deep ~cnous thrombosis will rcwlt in an 
ttltimate mortalitv from pultnotiar\ ctnl~olistn ot 
at least 6 per ten;. 
Posf/Md~itlc. S~ntlrornr: It is our l)c!ief tliitt the 
,,h~,ioF’atholr,~-ic process respon~iltle L:r ti;c 
de\ rloptnettt of this svndrotnc is cdetna wx~~~- 
tlar\ to \wwus insuficicnc~ Once pcrsistcnt 
cdc~na is pw~nt. distention of tissue ~pacrs and 
tltinnittz of the skin occur rr‘4tinq fr(jtn the 
ittcreawcl skin tension. The tltin ctlctnatous 
skin is IIIOX \usceptil)le to trauttta and wcondar\ 
infection. PcLrsistent inflammatii)n is foll~ve;! 
I))- induration, clccrea~e in local ar~rric:l;tr I~lootl 
suppI\- wcunclarv to focal hcarrine a~ttl ulti- 
mateli. ulwratiun. Raucr’ has 4to\vti that a5 
the titrtc of c,l)sc.r\-ation af1r.r tliv acute. thr~~tn- 
twtic cpiwc!r incrcaws, rhcrc is a pro$rwii\.c 
increabe in the incic!ence 01‘ indurati\-e and 
ulwrative chanqw. Follo\v-up ytuciic. on pa- 
ticnts, ft\,c to fifteen yc;tr\ after tltc acute’ cpiscclr~ 
Ita\.e tlctrton~trated an irtciclcnw of ulcr‘ratiott 
of the leq in tile ra:ify of from 20 to 30 prr cent : 
Hatter7 has olherwd ati c~\wi liiqlicr incidcticc 
(all in untreated patietlt\i. Zilliactts has 
reported tha: of 683 patient\ sur\.c\4 front six 
to fourteen )-cars after their tltr,:ti:l~otic cpisodc. 
ot-tl~ 6 pvr cenl had cotnplctcl~~ tiortit,rl legs: 
IO per cent \verc totally incapaciratcd and un- 
atIle to work and another 16 per cent hat1 had to 
chan,ye their occupations. ‘l‘h~~w olwr\-ations 
indicate that acute venous tltrontl~o5i~ and the 
hequelae of cdetna, inflamtnarion. induration 
and ulceration represent a clisal)lin~ tliwasc of 
major ma+tude. 
‘Tier Irntrrtzw diagnosis (!f tl,rornl!or~nit)iill~ d~st~~.w 
1s mn lndir<ltiorl for immdialr trrcltmrvl. The ol)jec- 
tives of treatment are to shorten the pcriocl of 
disaljility and lessen the incidence of complica- 
tions of deep venous thromt)osis. \Sc I)elicve 
that the optimal treattnent is prompr and effec- 
tivc anticoagulant therapy. \Vith this form of 
treatment Iwth mortality rate and posrphlebitic 
sequelac have been less than during the period 
when ligation of the femoral vein \va~ practiced. 
HEI’ARIN I’HERAPY 
Intrrmittd Intravenous Inyexfion: <he ina) 
obtain an almost instantaneous anticoagulant 
effect with the intravenous adtninistration of 
heparin (10 my:. per ml.) in closes of 75 to 100 
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rng. More concentrated forms of heparin ma) 
result in local burning pain at the site of intra- 
~YZIIO~S injection. Therap), can then IX con- 
tinued with any of se\-era1 technics. Intermit- 
tent intravenous injection of heparin in doses of 
7.i to 100 mg. at eight-hour intervals has been 
pro\,cd l)y a numl~er of Scandinavian workers to 
constitute satisfactory therapy, as indicated b) 
a reduction of thromhoembolic complications. 
Thix regimen provides a “picket-fence” response, 
clotting tirnes usually returning to normal within 
fi\-e hours after administration of 100 mg. of 
hcparin. The alternating return of clotting 
tirncs to normal values dots not appear to 
diminish the effecti\,eness of this therapy-. 
Although not absolutely essential, it is bise to 
cheek at least one clottrng time, just prior to a 
dose of heparin, to he certain that there is no 
curr~ulati\~e effect from prior doses. 
S~rhcuLanrouJ Injrc fion: An alternative method 
is the administration of concentrated aqueous 
hcparin (100 to 200 mg.,‘ml.) subcutaneousI>- 
at t\vclve-hour intervals. Individual doses \‘ar)- 
from 100 to 300 mg. The advantage of this 
method is that heparin ma)- be administered 11) 
the nursing staff in hospitals which require that 
. . 
a physrcran personally adrninister intravenous 
medications. The clisadvantag=e is that repeated 
determinations of clotting time are necessary to 
ad.just dosage to assure adequate effect without 
risk of hemorrhage. ,411 adequate anticoagu- 
lant eAPct will riot I)e obtained I)? this approach 
in a srnall percentage of patients, presumal~l~- 
l)ecause of hcparin-inactivating cnzyrries present 
in the subcutaneous tissues. 
In the past, several heparin preparations in- 
corporatcd in slowI>. at)sort)al)le menstrua ha1.e 
been used in deep subcutaneous iri,jection. \t’e 
have abandoned these lIecause of the frequent! 
of pain and hematomas at the site of injection 
and because of a somewhat unpredictable rc- 
sponse. 
Continmus Intrar~mous In/2rsion: In rare in- 
stances involving patients with a potential 
source of major hernorrhagc, there may be 
some advantage to the administration of heparin 
1,~ constant intravenous infusion. Aqueous 
hcparin, 250 to 300 nlg., is placed in 1,000 CC. 
of 5 per cent dextrose in water and infused, 
usually at a rate of 20 to 30 drops per minute, so 
that there is at least a twofold prolongation of 
the clotting tirne. This procedure obviates the 
extreme prolongation of clotting time which 
occurs imrnediately after the rapid administra- 
tion of a single dose of heparin. LTse of this 
technic requires rigid control of the t‘atc 01 
intravenous infusion to prcl’ent excessi\,e pro- 
longation of the clotting time and the risk of 
serious hemorrhage. 
H&ding Dur to Hrparin: One of the major 
advantages of heparin as an anticoagulant is that 
its effects on the clotting mechanism may be 
immediately reversed, in the event of IJceding 
or if the need for an ernergencj’ operation arises. 
t+ an intra\.enous iri.jection of protamine sulfate? 
usualI!- in an arnount equal, milligrarri for 
milligram, to the last dose of hcparin. 1 t stlould 
be rcrnembered that in cases of bleeding follo\v- 
irlg subcutaneous administration of heparin, 
lralf the protamine should I)e given t)y prompt 
intravenous injection and the remainder b). 
constant intra\.enous infusion over the period 
required for al)sorption into the IJood stream 
of the hepariri remaining in the suhcutancous 
depot. 
Oral anticoagulants provide greater cun- 
\-enience in the managernent of the usual case of 
thromboernl~olic disease. The initial dose of 
one of the drugs of the coumarin or indandione 
Lgroups is given at the tirne of the first dose of 
Iieparin. Heparin is continued until the Quick 
prothrombin activity has reached a satisfactor) 
Icvrl. It is essential that the initial and suhse- 
quent IAood specimens drawn for prothrornljin 
determinations IX obtained at a time when the 
heparin effect has completely suljsided, since 
some of the extraneous, predominantly ph) sical, 
elects of heparin may produce falsely low 
protlirombin activity values. Sut)sequent closes 
of the oral anticoagulant are determined on the 
Ijasis of dail>- Quick prothrombin activity levels. 
Except in urlusual circumstances, daily pro- 
thrornbin tirncs should he obtained for all 
hospitalized patients receiving anticoagulants, 
regardless of thr particular agent being used. 
There is considerable variation in opinion 
as to what constitutes effective therapy with oral 
anticoagulants. LTntil recently wc have at- 
ternptcd to maintain Lralues between 15 and 30 
per crnt activity. ,4 statistical study,g however, 
did not vield proof that a lesser effect was asso- 
ciated with any higher incidence of thromhoem- 
holic complications. For this reason, for the past 
several years, WC have maintained half of our 
patients treated with anticoagulants in the 30 
to SO per cent Quick prothrom.,in activit) 
range : it is still too early to obtain valid statis- 
tical data with regard to the comparative inci- 
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dence of bleeding and thromboembolic compli- 
cations in the two groups. 
=Idunnfr~~es of Thrious Orul Anticoagulants: It is 
our current opinion that there is no major 
therapeutic advantage of one oral anticoagulant 
over another. Our experience with all the 
clinicall\, available coumarin and indandione 
clerivati\.cs indicares that the thrornl~oeml~olic 
complication rate is not significantl>- 10~~3 
with 01x agent i han with another. :\djust- 
ment of drug dosay-e to maintain relatively con- 
stant prothromt)in activity values is easier with 
some agents than with others. It is preferable 
to gain extensive experience Lvith one anticoagu- 
lant, and this in itself facilitates proper managc- 
ment of dosage. Our own personal preference 
in trealing hospitalized patients is to use a short- 
acting anticoagulant, such as phenylindandionc. 
which can IX given on a twice-daily dosage 
schedule, or, rarel\,-, once a day in circumstance> 
of extrelne drug sensitivity. This system has the 
ad\.antaye that onl>, half of each day’s dose 01’ 
anticoagulant has l)ecn given at the time that 
the dail\- prothrombin activitv report is re- 
\-iexved. \Chen therapy is to I)e intcrruptecl 
for an)- reason, the return to normal prothrom- 
bin activity levels is relativcli. rapid. The. 
ion:-acting drug:, can IX adtninistered in ;I 
single daily dose or as infrequentl>- as once. 
every t\vo to five. days. It sccmx simpler to 
us to give doses of a drug at 24-hour intervals 
rather than to gauge dosage I))- waiting for 
protlirornbin activity values to jump to high0 
levels. Other investigators l)elie\-e that thcb 
long-acting anticoagulants are best given 1)). 
a schedule of administration in which a subsc- 
quent dose of the drug is given only when pro- 
thrombin activity- values indicate that the 
patient is escapin!; from the desired therapeutic 
range. 
Hmarrhage L)UP to Oral Anticoagulants: Bleeding 
due to an)- of the oral anticoagulants can be 
controlled by the intravenous or oral adminis- 
tration of vitamin K1 in doses of 5 to 50 mg. 
Except in rare instances of hemorrhage second- 
ary to gross overdosagc, bleeding will stop 
within four to eight hours, sometimes less, after 
the administration of vitamin I(,. Minor 
bleedin?, when continued anticoagulant treat- 
ment is contemplated, is best controlled bv de- 
creasing the anticoagulant dosage or 1,~ giving 
small amounts of vitamin K1 (5 to 10 mg). 
Larger doses of vitamin K1 may be followed b)- a 
prolonged period of refractoriness to the effects 
of oral anticoagulants. 
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The incidence of hemorrha$c complications 
in our series of patients treated \rith anticoagu- 
lants for deep venous thrombosis and or pul- 
monary embolism was 14.8 per cent. Most of 
the episodes wrre of a minor nature and did not 
intcrferc with continuation of tr‘catmcnt. h2a- 
_jol, bleeding (requiring blood rcplaccment 
and or cessation of anticoagulants) occurred in 
2.4 per cent of the treatment courses: in almost 
c\.rr!. instance this major I)lecdinq took place 
in an operati\,e wound or at the site of ;I pre- 
existing gastrointestinal lesion. Bleeding was 
successfully controlled by the rcqimcn cl~scribed 
in ever) instance. 
Ditralion of Anticoagulant ‘ficrrqt~y: As yet there 
ix no conclusive information with regard to the 
duration of ,mticoagulant therapy required 
to minimize thromboembolic complications. 
4nalysis of our patients in whom such conlplica- 
tions developed during or within twelve \veeks 
after the termination of therap)- permits several 
tentative conclusions. Anticoagulant treatment 
should ))p continued until the patient is free of 
all signs and symptoms and fully ambulator);. 
I:ailure to comply with either of these criteria 
will lead to a higher complication ratr. TYe 
have also found that added care is nccessar) 
in the treatmc‘nt of patients xvith heart disease 
in whom tmholic complications arc more 
frequent. Our complete anal!-& of thy cffec- 
tiveness of anticoagulant therapy has I)ecn pre- 
\iou$ly pulJishedg; it should IX stressed here, 
however, thal fatal pulmonar)- enil)oli subse- 
quent to the initiation of anticoagulant treat- 
ment were four times more frequent in those 
patients who had one or more pulmonar>- emboli 
lIefore the diagnosis was made and therap) 
instituted. 90 anticoagulant will disso1L.e exist- 
ent thrombi; the functions of anticoagulant 
agents are to prevent further propagation of a 
fresh friable thromhus and to permit orqaniza- 
tion of the thrombus alread\- preycnt. 
P1..4SMIN AND I’LASMIN ACTIWATOKS 
There has been considerable enthusiasm in 
the past several years concerning the role of 
plasmin and certain plastnin activators (strep- 
tokinase, urokinase) in the treatment of throm- 
boembolic disease. Good objectivr evidence 
that these agents reduce either morbidity or 
mortality from thromboembolic disease is lack- 
ing at the present time. Years of competent 
investigative work and accumulation of statis- 
tical data will be necessary before the value of 
these agents can be determined. There are no 
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well controlled studies to suggest that intra- 
muscular or sul)lingual enzyme preparations 
ha\:e anv value whatsoever. .A number of 
laborator&, including our own, have shown 
that circulating fil)rinolytic enzyme has a pro- 
found effect o11 the proteolytic degradation of 
fibrin and fibrinogen. However, a I)lood clot 
and an intravascular thromhus should 1~ con- 
sidered as separate and distinct entities. The 
intravenous administration of high concentra- 
tions of non-pyrogenic plasmin or plasmin 
activator to a patient with a thrombus less 
than seventy-two hours old may suljsequently 
t)c shown to I)c an effective and safe method for 
complete and permanent dissolution of intra- 
vascular throml)i; however, until this is con- 
clusivcly demonstrated b)- o))jecti\-r technics, 
these agents should he restricted to clinical 
in\.cstiqa tive use. 
The indication for \,ein ligation, in our 
opinion, is the presence of a contraindication 
to, or the failure of, anticoagulant therapy. 
C:ontraindic~~tion to the use of either heparin or 
oral anticoagulants is limited to those patients 
in whom the risk of bleeding is so great, or in 
wllom the result of ljleeding would IX so serious, 
that the use of any drug which will alter the 
clotting mechanism is not warranted. Patients 
who have had recent operations ml the eye, 
I)rain or spinal cord or with a history of recent 
cereljral hemorrhage and those who ha\ e had a 
recent prostatectomy-, particularly l)y trillis- 
urethral rcscction, fit into this category. 
Progression of venous thrornbiis or recurrent 
pulmonary einljolism seems to occur more frr- 
quently during treatment with oral anticoagu- 
lants than with heparin. \Vhen this occurs, 
heparin therapy should bc instituted and, in 
most instances, no further complications will 
result. However, if a second complicating pul- 
monary cmbolus should occur, operative treat- 
ment is recommended. 
Ina COVCI fiiltrr: Since the development b) 
De\$‘eese and I-iunter’o of a “\:ena cava filter” 
wc’ have recommended this procedure as the 
operation of choice. This technic involves the 
placement in the inferior vena cava Just below 
the renal veins of one or two rows of interlacing 
angulated silk sutures which tend to trap any 
dislodged emboli. It has the advantage of 
removing any emboli of significant size from the 
venous circulation without resulting in complete 
interruption of caval blood flow, which would 
occur with ligation. Extensive animal stuclies 
and the results in five human subjects with 
multiple prior pulmonary enit)oli ha\.c slio\\-n 
this to hc a safe and effecti\.c proccclurc, not 
followed to date I)? the extremely clisaI)ling 
sequelae associated with caval ligation. In all 
five patients on whom this operation \vas !,er- 
formed the indication was repeated pulmunar~- 
emholi, rather than contraindication to anti- 
coagulant therapy, therefore, it was possil)le to 
administer anticoagulants durirlg tile postopcra- 
tive period : this may have helped to minimize 
thrombosis around the silk suture material until 
pseudoendothelialization had taken place. 
I;umoral 01 I arm c”mnl Ligcition. \lT:c t1a\ (’ COIll- 
mented in the past on the fallacy of rrliancc% wl 
superficial ligation of the Ic1llora1 \ c%i 25 2 
measure to prc\.cnt pulmonary cnil~oli~~n. As 
McLachlin and Paterson” ha\,c sho\vn. O\.CI 
half of deep \.cnous thrombi are found in loca- 
tions where t)ilatcral superficial ligation of ttic 
femoral vein will not prevent suJ)sequcnt vml)o- 
lism. Rilatcral common femural or \‘c‘nii ca\.al 
lie-ation arr more cffectivc t)ut arc ;rsociatrcl ,, 
with a much hi&rlr incidence uf postptllcl)itic 
scquelae: in addition, all thrsc procedurc5 ha1.c 
I )een follo\vctl ) 1) it significant po5tliy:ltion 
mortality froni fatal pulmonary cnil)vli ;lriSiny 
from throml)i propaqatiIi,y just prosilnal to the 
5ite of ligation. It is for these reason\ that \v( 
restrict our operative proccclurcs to the. indica- 
tions listed Ilcrcin, and prcfcr to continue. out 
e\-aluation of tlic vcna cava filter rather than to 
carry out ligation pur sp. 
Brief comment has I)een made pre\iousl>- on 
additional measures of value in the trcatmrnt of 
phlegmasia cerulca dolens. If there exists 
arteriospasni of a deyrce sufficient to compro- 
mise the arterial circulation, immediate trcat- 
mrnt is csscntial. Cbntinuous cpidural syn- 
pathetic block should l)e instituted I)y inxrrtion 
of a polyethylcnr catheter into the epiclural 
space with intermittent injection of a local 
anesthetic for periods of several days to ;I \vcck 
or longer. To minimize the possiblity of local 
bleeding it is essential that the catheter I)c 
inserted prior to the t)eginnin,y of heparin ther- 
apy. It is our impression that the latter agent 
is the preferat& anticoagulant because of its 
apparent beneficial effect in relieving vasospasm. 
Rapid improvement is usually observed; epi- 
dural catheters have been kept in place for as 
long as ten day but can frequently he removed 
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within forty-eight to seventy-two hours while 
heparin therapy is continued for a consideraM> 
longer period. 
ANC;ILL:\RY MEASURES 
The ancillary non-specific measures used in 
the treatment of thromhoembolism are well 
known and include bed rest until signs and 
S~tnptot~lz: subside, repeated careful elastic 
l;andag:-c wrapping of the legs, elevation (6 tcr 
8 inches) of the foot of the bed and finall!., 
progressive ambulation with adequately 
wrapprd legs while anticoagulants are still being 
adminiqtered. Antibiotics ha\-e no place in 
the thrrap!- of tile uncomplicated aseptic form 
of deep ~cnous thrombosis. Prophylactic anti- 
ICotics ma!. be of value in patients Lvith pul- 
tnonar\ cml~olism to reduce subsequent sec- 
ondar) infection of pulmonary infarcts. 
True, septic thromhophlebitis is a separate 
and distinct disease entity. Pathologically, 
I)acteri;rl colonies are demonstrable in the 
throml)us. The high frequency of septic 
cml)oli in this condition makes the treatment of 
choice specific antibiotic therapy and \,ein 
interruption \\-ell above the site of thromlSs 
\\-itll ~ul)~cquent anticoagulant therap)- to 
prr\-yl:t sc,condar) propagation of throml)us 
proximal to the site of ligation. 
TRE.\‘t’\IEXT OF Pl’LMONARY EMBOLISM 
‘The therapeuric measures used to treat acute 
pulmonar!- emtlolism seem to have little cf- 
feet in altering prognosis. The administration 
of narcotics, oxygen, aminoph>-lline, atropine 
or papavcrine may provide symptomatic re- 
licl” I)ut thr)- have not been shown to lessen 
mortalit!- either experimentally or clinicall!-. 
7‘11~ IIW of norepinephrine to treat hypotension 
secontlar>~ to acute cur pulmonale has been 
sho\vn to alter the mortality rate from experi- 
mental pulmonar)- embolism in dogs’” and ma) 
have bomc specific value in man. Unfortunately, 
fatal cml>olic episodes in our series produced 
dcarh in almost half of the patients in less than 
fiftr.ell minutes from the onset of symptoms: 
this lea\-eq little time in such a group at least 
for tile institution of specific therapy, even if 
it \vcrc availat)l(y. 
PREVI-NTtON ANI) TREATMENT OF EDEILt.4 
7‘hc treatment of deep venous thrombosis 
does not end with the acute episode. It is 
essential that Ihe patient he instructed in a 
proSram whicl; will prevent the de\-elopment 
of edema, since this is the first and essential 
element in the progressive pathologic changes 
\vhich result in the full postphlebitic syndrome. 
Our patients are instructed to wrap their legs 
to the knees with elastic bandages before the) 
yet up in the morning and to wear these sup- 
ports as long as the); are on their feet for a period 
of from six weeks to six months. .\ trial at 
full activity without support is then begun; 
if any edema of his legs develops, the patient 
returns for measurement and fitting of elastic 
stockings designed and tnade to fit his edema- 
free leg. In addition, these patients are in- 
structed to sleep with the foot of the mattress 
elevated 6 to 8 inches. Rest during the day with 
the legs ele\.ated is advised if an>- discomfort is 
noted. 
It is important that elastic stockings be in- 
dividually constructed to the patient’s own Icy 
measurements. Hydrodynamic studies have 
shown that valvular incompetence in the re- 
canalized deep \-enous system results in per- 
sistent elevation of venous pressure cornparat~le 
to the pressure exerted by a column of watrr 
reaching to heart level. Pressure is greatest at 
the level of the ankle and foot and progrrssivcl) 
decreases as one moves up the leq. It is im- 
portant that elastic stocking;s are nlade to 
counteract these pressure relationships I)) cx- 
erting the greatest pressure at the ankle area, 
with progressively less compression further up 
the lee. The form of the stockin? Lvill var\- 
wirh the contour of the individual leg. If the 
pressure dots not progrcssi\-cl!- decrease: thrre 
may he an area of too great \-enous cotnpression 
at one point, Lvhich ma)- actualI\- hampet 
venous return and do more harm than good. 
Patients who have carefully followed this 
regimen from the time of the acute tliroml)otic 
episode haves t)een free of advanced skin change 
and ulceration. Occasionall\- pain it) the leg 
or fatigue lnav occur, 
quelae do not. 
Ijut tlit, disai)lin~ sc- 
PREVENTION OF THROMBOEMBOLlSM 
Prior comments on the extreme difficult)- 
and the inaccuracy of the clinical diagnosis of 
thromhoemt)olic disease were not meant to 
create an atmosphere of therapeutic nihilism. 
However, we must be realistic ahout lvhat we 
can accomplish, even with maximal clinical 
diagnostic accuracy, in our therapeutic at- 
tempts to lower the disabilit>- and mortalit! 
from this disease. 
Roughly, at the present time, we diagnose 
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about 10 per cent Of the cases Of deep \ enous 
thrombosis. AnOther 10 per cent Ila\~ come 
localizing sign which should result in rhc diag- 
nosis of this entity. The remainder, however, 
have no recogniza t)le clinical signs which may 
Ix utilized for e\.cn a presumptive dialgnOsis. 
In 0111~ series at lcast (substantiated I)y others”‘~ Id), 
tile diagnosis Of pulmonary emholism is less 
accurate. In man); instances, the first pul- 
IIX~~I~): emholus is the fatal One. 
Utilizing a critical approach fOr the analysis 
of‘ ttic \,aluc Of anticoagulant therap)-, M‘C have 
estimated that anticoagulant treatment, as 
now practiced, will saltrage at least seven of 
every ten patients who would have died frclm 
fatal embolism had anticoagulants not Imm 
uced !# L . These figures were obtained with the 
assumption that an): unexplained sudden death 
occurring in a patient within twelve weeks after 
the terminaticm of anticoagulant therap) was 
due to pulmonary emt,olism. The true rate 
Of salvage with anticoagulant therap). is pr01,- 
ably somewhat better than this. 
Even assuming that the patients in whom WC 
do make a positive diagnosis represent a higher 
proportion or those patients with more ad- 
\-anced and more serious forms Of throml,o- 
cml)olism, it Lvould not seem unreasonal& 
to cstitnate that we treat only One patient in 
cictlt with fatal or potentially fatal (without 
anticoagulanl treatment) pulmonary- cmholism. 
If one is willing to accept these assumptions, 
then it must be recognized that we will diagnose, 
treat and salvage only- a small proportion Of 
those pafienls in whom one can expect fatal 
pulmonary embolism to develop. Maximal 
improvement in Our diagnostic accurac). might 
result in a twofold increase in the numlxr Of 
patients treated, Ijut even this will rrpresent 
WI\ age of onl:, ;L small pcrcentagc uf expected 
fatalities. 
Prof~fylactic Antmugulant ‘Therapy: However, 
\ve have not yet contracted the nihilistic con- 
ta+on and still regard thromhocml)olism as a 
theoretically preventable disease. Every at- 
tempt should IX made to impro1.e diagnostic 
accuracy and this should result in a slight re- 
duction in disability and mortality. At Our 
present state Of knowledge, lacking a satis- 
factor)- diagnostic test, the mOst rational ap- 
proach to a significant decrease in mortalit) 
and morbidity seems to be the utilization Of 
prophylactic anticoaaulant therapy in a SP- 
lccted Froup of patients in whom the risk Of 
thrumt~oeml~olic complications is greatest. 
Irtilizing sonit~ of’ the cpiclf3~iiologic data tllat 
ha\ c‘ heen accumulated, we recOmmetld that 
the clinician scrlousl~ consider the value Of 
using prophylactic anticoagulants in those 
patients with a Iligh predisposition to thrumt~O- 
embolic disease \\.ho must 1~ immo’r~ilizrd in 
IWd. ‘4s mentioned earlier, the greatest risk 
occurs in patients lrith a prior history of tllt-orri- 
l)ocmbolism, in older people with heart disease 
or with certain t\ pcs of cancer, and in an) pa- 
tients with trauma to the leg Or extreme r,i,csit). 
\Ve now recommend proph\~lactic anticoagulant 
therapy in all patients with prior thrornl~o- 
embolism, conqc\tive heart failure or extrcltir 
obesity and arc planning to extend Our indica- 
tiuns to the orhrr categories list& licrcill. 
The risks Of anticoa,yulant therap)- are far lcrs 
than the incidence of tllrolnl)oeml,olic com- 
plica tions in thcsc pat icnts. The results should 
justif? the tiinr atid cxpensc required to cat’r) 
Out such a prograln. Cintil WC find methvds for 
the early labora tar!- diagnosis of \‘enous tlirorii- 
I)osis, this secm5 to l)c the only a\2ilat)lc ap- 
proach capaljlc (pi’ effecting a significant I-C- 
tluctiotl in the illcidcrlcc of tllis disease. 
‘l‘he manifesta Lions of tkro~iil~oenit~olism are 
highlv variable and frequently obscure. (Yin- 
ical diagnosis of 111csc cntitics is diflicult, and 
the majority Ol cacc\ will not 1~ diagnosed 1)). 
the means presently available to us. Nevertllc- 
less, a heightened awareness of the vagaries of 
this disease call result in considerable impro\,e- 
mcnt in diagnclstic accuracy. Ptompt diagnosis 
on tile basis Of the slightest clinical suspicion, 
followed by immediate- and adequate antico- 
agulant therapy, should result in a measureal)le 
decrease in tliro~nl~oeml~olic complications. 
IIuwevcr, if one hopes to achic\,e a proti)und 
reduction in incidence of tt~romboembolisl~~, 
the [ml\- approach presently available is pro- 
phylactic rather than therapeutic. The use of 
measures to increase \.enuus return in patients 
who are immol~ilizccl in /led, plus the institution 
of prophylactic anticoagulant therapy in a 
selected group of patients with a high predis- 
position to the development of thromt~oeml~olic 
diseases, should rchult in a significant reduction 
in disability and ~nortali~y frown this throreticall) 
pre\,cntahle discasc. 
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